Simplex Trading’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-47,159
| Closed | -$150K | – | 9368 |
|
|
2025
Q4 | $189K | Buy |
47,159
+41,742
| +771% | +$232K | ﹤0.01% | 4291 |
|
|
2025
Q3 | $45K | Sell |
5,417
-30,501
| -85% | -$296K | ﹤0.01% | 6567 |
|
|
2025
Q2 | $404K | Buy |
35,918
+32,142
| +851% | +$295K | ﹤0.01% | 3739 |
|
|
2025
Q1 | $35K | Sell |
3,776
-69,904
| -95% | -$706K | ﹤0.01% | 6109 |
|
|
2024
Q4 | $828K | Buy |
+73,680
| New | +$1.29M | ﹤0.01% | 3025 |
|
|
2024
Q3 | – | Sell |
-27,364
| Closed | -$705K | – | 8779 |
|
|
2024
Q2 | $523K | Buy |
+27,364
| New | +$699K | ﹤0.01% | 3622 |
|
|
2024
Q1 | – | Sell |
-82,478
| Closed | -$2.63M | – | 9114 |
|
|
2023
Q4 | $2.72M | Buy |
+82,478
| New | +$2.33M | ﹤0.01% | 2096 |
|
|
2023
Q3 | – | Sell |
-1,200
| Closed | -$33.4K | – | 8963 |
|
|
2023
Q2 | $36K | Buy |
+1,200
| New | +$38.8K | ﹤0.01% | 6152 |
|
|
2023
Q1 | – | Sell |
-6,381
| Closed | -$202K | – | 9312 |
|
|
2022
Q4 | $179K | Sell |
6,381
-10,126
| -61% | -$290K | ﹤0.01% | 4347 |
|
|
2022
Q3 | $593K | Buy |
16,507
+14,432
| +696% | +$508K | ﹤0.01% | 3266 |
|
|
2022
Q2 | $63K | Sell |
2,075
-29,737
| -93% | -$867K | ﹤0.01% | 6181 |
|
|
2022
Q1 | $1.03M | Buy |
+31,812
| New | +$833K | ﹤0.01% | 2884 |
|
|
2021
Q4 | – | Sell |
-17,976
| Closed | -$516K | – | 10719 |
|
|
2021
Q3 | $379K | Hold |
17,976
| – | – | ﹤0.01% | 4527 |
|
|
2021
Q2 | $379K | Buy |
17,976
+5,622
| +46% | +$113K | ﹤0.01% | 4588 |
|
|
2021
Q1 | $0 | Sell |
12,354
-17,262
| -58% | -$328K | ﹤0.01% | 9120 |
|
|
2020
Q4 | $474K | Buy |
+29,616
| New | +$391K | ﹤0.01% | 3495 |
|
|
2020
Q3 | – | Sell |
-16,528
| Closed | -$194K | – | 7963 |
|
|
2020
Q2 | $117K | Sell |
16,528
-4,574
| -22% | -$30.6K | ﹤0.01% | 4639 |
|
|
2020
Q1 | $114K | Sell |
21,102
-16,641
| -44% | -$149K | ﹤0.01% | 4221 |
|
|
2019
Q4 | $341K | Sell |
37,743
-7,522
| -17% | -$61.1K | ﹤0.01% | 3135 |
|
|
2019
Q3 | $325K | Buy |
45,265
+43,172
| +2,063% | +$310K | ﹤0.01% | 3083 |
|
|
2019
Q2 | $16K | Sell |
2,093
-942
| -31% | -$11.2K | ﹤0.01% | 5774 |
|
|
2019
Q1 | $38K | Sell |
3,035
-8,397
| -73% | -$133K | ﹤0.01% | 5228 |
|
|
2018
Q4 | $228K | Buy |
+11,432
| New | +$264K | ﹤0.01% | 3010 |
|
|
2018
Q3 | – | Sell |
-15,535
| Closed | -$371K | – | 7564 |
|
|
2018
Q2 | $327K | Buy |
+15,535
| New | +$294K | ﹤0.01% | 2913 |
|
|
2018
Q1 | – | Sell |
-1,886
| Closed | -$27K | – | 6322 |
|
|
2017
Q4 | $23K | Sell |
1,886
-52,475
| -97% | -$740K | ﹤0.01% | 3171 |
|
|
2017
Q3 | $967K | Buy |
54,361
+14,987
| +38% | +$309K | 0.04% | 390 |
|
|
2017
Q2 | $998K | Sell |
39,374
-3,797
| -9% | -$91.3K | 0.04% | 365 |
|
|
2017
Q1 | $962K | Buy |
43,171
+31,992
| +286% | +$614K | 0.04% | 396 |
|
|
2016
Q4 | $165K | Buy |
11,179
+11,026
| +7,207% | +$217K | 0.01% | 1182 |
|
|
2016
Q3 | $3K | Buy |
+153
| New | +$3.58K | ﹤0.01% | 4668 |
|
Other funds holding EVH
CCM
RF
EC
VCM
RSCM
Simplex Trading's EVH Position: Q1 2026 in Review
Simplex Trading sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 47,159 shares — an estimated $150K sold.
Simplex Trading first reported a position in EVH in Q3 2016 and held it in 30 quarters. The position peaked at $2.72M in Q4 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.
- Simplex Trading reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 47,159 Evolent Health shares in Q1 2026, an estimated $150K.
- Simplex Trading first reported a position in Evolent Health in Q3 2016 and held it in 30 quarters.
- Simplex Trading's Evolent Health position peaked at $2.72M in Q4 2023.
- 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.